$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 3.72% on an annualized basis producing an average annual return of 14.82%. Currently, Stryker has a market capitalization of $144.52 billion.
Marksmen Energy Inc. Provides Update on the Filing of its 2024 Annual Financial Statements and Q1 Interim Financial Statements
CALGARY, ALBERTA, June 12, 2025 ( GLOBE NEWSWIRE ) -- Marksmen Energy Inc. ( "Marksmen" or the "Company" ) is providing this update further to its news releases dated May 15, 2025 and May 29, 2025 with respect to the Alberta Securities Commission ( "ASC" ) , having issued a management cease ...
Will GameStop Buy More Bitcoin? Shares Plunge Amid 'Black Box' Criticism Over Strategy
The company's stock price fell 22% on Thursday after it unveiled plans to offer investors $1.75 billion worth of convertible bonds.
CUNARD'S NEWLY REFRESHED QUEEN ELIZABETH ARRIVES TO SEATTLE FOR THE FIRST TIME IN A SPECIAL SERIES OF VOYAGES TO ALASKA - Carnival ( NYSE:CUK ) , Carnival ( NYSE:CCL )
Alaskan voyages mark the beginning of Queen Elizabeth's North American residency as she prepares for her highly anticipated maiden season of Caribbean voyages starting in October A plaque-and-key ceremony celebrated the arrival in Seattle where the Cunard ship will homeport from June to September
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - NVIDIA ( NASDAQ:NVDA ) , Novo Nordisk ( NYSE:NVO ) , IQVIA Hldgs ( NYSE:IQV )
Novo Nordisk will use Nvidia BioNeMo, NeMo microservices, and Omniverse for AI drug discovery. IQVIA's AI agents will analyze treatment data in days instead of weeks for faster development. 3 Summer 'Power Patterns' Are About to Trigger ( One With 90% Win Rate ) - Get The Details Now
Palantir Technologies ( PLTR ) Pulls Back After Hitting All-Time High: What's Going On? - Palantir Technologies ( NASDAQ:PLTR )
Palantir stock rallied to a new all-time high Wednesday, driven by recent positive developments. Today, the stock is experiencing a modest pullback from its impressive record-setting peak. Historic Summer Setup: 3 'Power Patterns' Triggering in the next 75 Days - Get The Details Now
Is This Stock a Buy After Acquiring a Potential Zepbound Competitor?
Shares of Regeneron ( NASDAQ: REGN ) have declined this year due to issues with one of its former growth drivers, Eylea, a medicine that treats wet age-related macular degeneration. The therapy is facing stiff competition, biosimilar and otherwise, that is eating into its market share.However, ...
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - CureVac ( NASDAQ:CVAC ) , Novavax ( NASDAQ:NVAX )
CureVac shareholders will receive about $5.46 per share in BioNTech ADSs; the deal values CureVac at ~$1.25 billion. CureVac holders will own 4%-6% of BioNTech post-deal; closing is expected in 2025. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here.
BlackRock Targets $280 Billion Market Cap, $35 Billion Revenue By 2030 - BlackRock ( NYSE:BLK )
BlackRock plans to raise $400 billion in private markets and grow revenue to over $35 billion by 2030. Aladdin generated $1.6 billion in 2024 and will integrate Preqin data to expand into private market indexing. Get access to the leaderboards pointing to tomorrow's biggest stock movers.